Viewing nowCombinationTelostop Plus Tablet 40/5/10 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201801980 · Approved 2018.05.10 · Insurance code 642906000
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerotic progression and cardiovascular disease risk
This medication is used in patients taking telmisartan and amlodipine combination who have uncontrolled blood pressure with monotherapy, and in patients who require concomitant treatment with rosuvastatin. The telmisartan/amlodipine combination is primarily used for the treatment of essential hypertension and is effective in cases where blood pressure control is difficult. Rosuvastatin calcium assists in dietary management for patients with primary and familial hypercholesterolemia, mixed hyperlipidemia, and abnormal beta-lipoproteinemia, helping to lower total cholesterol and LDL cholesterol levels, thereby delaying the progression of atherosclerosis. Furthermore, it has been demonstrated to reduce the risk of stroke, myocardial infarction, and revascularization procedures in high-risk cardiovascular patients. This drug improves blood pressure and cholesterol management in patients who have both hypertension and dyslipidemia.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended that you take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking the telmisartan/amlodipine combination together with rosuvastatin as a single ingredient, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before starting the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, and most patients achieve control at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 mg once daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of rosuvastatin at a dose of 40 mg is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, in the presence of telmisartan/amlodipine, rosuvastatin Cmax increased approximately 2.4-fold and AUC approximately 1.3-fold. Therefore, when administering this medicine, assess the potential risk associated with the increase in rosuvastatin Cmax and monitor patients closely.
This medication can cause serious harm to the fetus and newborn during pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. Patients who are allergic to this drug or similar components, or have certain medical conditions should not take it. Patients with significantly impaired liver or kidney function, history of angioedema, or certain heart diseases require special caution when taking this medication. Elderly patients, those with very low blood pressure, or high potassium levels should use this medication cautiously, and liver function and muscle state should be checked regularly as needed. This medication may cause muscle-related side effects such as myalgia or muscle weakness, so if these symptoms occur, consult a doctor immediately. There may be interactions with other medications when taken together, so it’s essential to inform the physician or pharmacist of any other medications being taken. Pregnant or nursing women are recommended not to take this medication, and women of childbearing age should use appropriate contraception. Safety in children has not been sufficiently confirmed, and it is advised not to use it in children under 18 years old. Overdosage may result in symptoms such as hypotension, abnormal heart rhythms, and dizziness, so care should be taken not to exceed the recommended dosage, and if an overdose is suspected, immediate medical attention should be sought. Store this medication out of reach of children and do not transfer it to other containers.
Viral upper respiratory tract infection, dyspnea, hemorrhoidal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastroenteritis, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory infection, low back pain, sinusitis, diarrhea, pharyngitis, influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, sensory disturbances, involuntary muscle contractions, erectile dysfunction, increased sweating, flushing, allergy, fever, leg pain, lethargy, vascular edema, itching, rash, eczema, vascular edema, erythema multiforme, vasculitis, peripheral neuropathy, tremor, loss of appetite, constipation, dysphagia, pancreatitis, vomiting, gingival hyperplasia, asthenia, burning sensation, rigidity, weight gain, weight loss, erectile dysfunction, insomnia, neurogenic irritability, depression, abnormal dreams, anxiety, depersonalization, thrombocytopenia, leukopenia, purpura, thrombocytopenia, headache, dizziness, constipation, nausea, abdominal pain, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptom drug reaction syndrome, lupus-like syndrome, muscle rupture, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, edema, palpitations, hypotension, hyperkalemia, hypoglycemia, syncope, low back pain, muscle cramps, thrombocytopenia, increased serum creatinine, acute renal failure, oliguria, liver function abnormalities, liver disease, vascular edema, thrombocytopenia, increased serum creatinine, acute renal failure, oliguria, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, it is important to maintain a temperature between 1 to 30 degrees Celsius when storing the medication. This helps ensure its efficacy is preserved safely.
Pink oval film-coated tablet
30 tablets (10 tablets x 3)/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
DaeWon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.